SCHEMBL3951014

SCHEMBL3951014

C=C(C#N)/C=C/c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.48
▸ LMNA P02545 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ HDAC3 O15379 2/20 0.48
▸ HDAC4 P56524 2/20 0.48
▸ HDAC1 Q13547 2/20 0.48
▸ HDAC2 Q92769 2/20 0.48
▸ HDAC8 Q9BY41 2/20 0.48
▸ HDAC6 Q9UBN7 2/20 0.48
▸ PLIN1 O60240 2/20 0.48
▸ RECQL P46063 2/20 0.48
▸ PLIN5 Q00G26 2/20 0.48
▸ ABHD5 Q8WTS1 2/20 0.48
▸ F3 P13726 2/20 0.48
▸ TNKS O95271 1/20 0.48
▸ HCAR2 Q8TDS4 1/20 0.48
▸ HDAC7 Q8WUI4 1/20 0.48
▸ HDAC10 Q969S8 1/20 0.48
▸ HDAC11 Q96DB2 1/20 0.48
▸ TNKS2 Q9H2K2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3437188 1.00 MAPT (0.48) MAPTLMNAALDH1A1HDAC3HDAC4
Acrylonitrile SCHEMBL29191949 0.93 KDM4E (0.44) MAPTLMNAALDH1A1HDAC3HDAC4
SCHEMBL25633237 0.80 MAPT (0.47) MAPTALDH1A1CYP2C9SMN1; SMN2MAOB
SCHEMBL6688122 0.79 MAPT (0.54) MAPTLMNAALDH1A1HDAC3HDAC4
SCHEMBL7935925 0.79 MAPT (0.54) MAPTLMNAALDH1A1HDAC3HDAC4
(Z)-1,2-Diphenylethene SCHEMBL4447909 0.78 MCL1 (0.44) MAPTLMNAALDH1A1HDAC3HDAC4
SCHEMBL21758829 0.76 LMNA (0.42) MAPTLMNAALDH1A1HDAC3HDAC4
Styrene SCHEMBL27564913 0.76 ALDH1A1 (0.48) MAPTALDH1A1HDAC8SMN1; SMN2TDP1
Styrene SCHEMBL10775344 0.76 ALDH1A1 (0.48) MAPTLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL551223 0.76 MAPT (0.54) MAPTLMNAALDH1A1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 — — US disclosed
EP-2043606-A2 NANOPARTICULATE KINASE INHIBITOR FORMULATIONS Elan Pharma International Limited (IE) 2009-04-08 — — EP disclosed
CN-100413845-C Compounds for modulating cell proliferation HSC RES & DEV LTD (CA) 2008-08-27 — — CN disclosed
WO-2007146943-A2 NANOPARTICULATE KINASE INHIBITOR FORMULATIONS ELAN PHARMA INTERNATIONAL LTD. (IE) 2007-12-21 — — WO disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 — — US disclosed
EP-1727822-A4 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2007-05-09 — — EP disclosed
EP-1752446-A3 Compounds for modulating cell proliferation HSC Research and Development Limited Partnership (CA) 2007-03-21 — — EP disclosed
EP-1752446-A2 Compounds for modulating cell proliferation HSC Research and Development Limited Partnership (CA) 2007-02-14 — — EP disclosed
WO-2007006143-A1 COMPOSITIONS AND METHODS FOR DETECTING TRANSFORMED CELLS THE HOSPITAL FOR SICK CHILDREN (CA) 2007-01-18 — — WO disclosed
EP-1272457-B9 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2006-12-20 — — EP disclosed
WO-2005092904-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2005-10-06 — — WO disclosed
US-20040209845-A1 Novel compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2004-10-21 — — US disclosed
US-6800659-B2 NOVEL STYRYLACRYLONITRILE COMPOUNDS WHICH ARE USEFUL IN TREATING A VARIETY OF CELL PROLIFERATIVE DISORDERS SUCH AS CANCER ARE DISCLOSED. A METHOD OF MODULATING CELL PROLIFERATION COMPRISING ADMINISTERING AN EFFECTIVE AMOUNT OF HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2004-10-05 — — US disclosed
US-20040072803-A1 Novel compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED (CA) 2004-04-15 — — US disclosed
CN-1429202-A Compounds for modulating cell proliferation HSC RES & DEV LTD PARTNERSHIP (CA) 2003-07-09 — — CN disclosed
US-20030109502-A1 Novel compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2003-06-12 — — US disclosed
EP-1272457-A2 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC Research and Development Limited Partnership (CA) 2003-01-08 — — EP disclosed
WO-2001079158-A3 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2002-01-31 — — WO disclosed
WO-2001079158-A2 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2001-10-25 — — WO disclosed
US-3943161-A Process for producing conjugated dienes containing a cyano group TOYO SODA MANUFACTURING CO., LTD. (JA) 1976-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation MKI67, CCNA1, PCNA MAPT 4784/4885LMNA 2293/4885ALDH1A1 546/4885
US-20040209845-A1 Novel compounds for modulating cell proliferation MKI67, CCNA1, CCNI MAPT 4740/4885LMNA 1972/4885ALDH1A1 178/4885
US-20030109502-A1 Novel compounds for modulating cell proliferation MKI67, CCNA1, CCNI MAPT 4740/4885LMNA 1972/4885ALDH1A1 178/4885
US-20040072803-A1 Novel compounds for modulating cell proliferation MKI67, CCNA1, MCL1 MAPT 4762/4885LMNA 2144/4885ALDH1A1 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback